1.Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review.
Bruno José Martins Da SILVA ; Amanda Anastácia Pinto HAGE ; Edilene Oliveira SILVA ; Ana Paula Drummond RODRIGUES
Journal of Integrative Medicine 2018;16(4):211-222
Leishmaniasis, a neglected disease caused by Leishmania protozoans, primarily affects people in tropical and subtropical areas. Chemotherapy based on the use of pentavalent antimonials, amphotericin B, paromomycin, miltefosine and liposomal amphotericin B is currently the only effective treatment. However, adverse effects, long-term treatment and the emergence of parasite resistance have led to the search for alternative treatments. Natural products used in traditional medicine provide an unlimited source of molecules for the identification of new drugs, and the Amazon region has abundant biodiversity that includes several species of plants and animals, providing a rich source of new products and compounds. Although the literature describes numerous promising compounds and extracts for combating Leishmania protozoans, the results of such research have not been embraced by the pharmaceutical industry for the development of new drugs. Therefore, this review focused on the antileishmanial activity of extracts, isolated compounds and essential oils commonly used by the local population in the Brazilian Amazonian region to treat several illnesses and described in the literature as promising compounds for combating leishmaniasis.
Animals
;
Antiprotozoal Agents
;
chemistry
;
isolation & purification
;
pharmacology
;
Brazil
;
Humans
;
Leishmania
;
drug effects
;
genetics
;
growth & development
;
Leishmaniasis
;
drug therapy
;
parasitology
;
Plant Extracts
;
chemistry
;
isolation & purification
;
pharmacology
;
Plants, Medicinal
;
chemistry
2.Antileishmanial and Cytotoxic Effects of Essential Oil and Methanolic Extract of Myrtus communis L..
Hossein MAHMOUDVAND ; Fatemeh EZZATKHAH ; Fariba SHARIFIFAR ; Iraj SHARIFI ; Ebrahim Saedi DEZAKI
The Korean Journal of Parasitology 2015;53(1):21-27
Plants used for traditional medicine contain a wide range of substances that can be used to treat various diseases such as infectious diseases. The present study was designed to evaluate the antileishmanial effects of the essential oil and methanolic extract of Myrtus communis against Leishmania tropica on an in vitro model. Antileishmanial effects of essential oil and methanolic extract of M. communis on promastigote forms and their cytotoxic activities against J774 cells were evaluated using MTT assay for 72 hr. In addition, their leishmanicidal activity against amastigote forms was determined in a macrophage model, for 72 hr. Findings showed that the main components of essential oil were alpha-pinene (24.7%), 1,8-cineole (19.6%), and linalool (12.6%). Findings demonstrated that M. communis, particularly its essential oil, significantly (P<0.05) inhibited the growth rate of promastigote and amastigote forms of L. tropica based on a dose-dependent response. The IC50 values for essential oil and methanolic extract was 8.4 and 28.9 mug/ml against promastigotes, respectively. These values were 11.6 and 40.8 mug/ml against amastigote forms, respectively. Glucantime as control drug also revealed IC50 values of 88.3 and 44.6 mug/ml for promastigotes and amastigotes of L. tropica, respectively. The in vitro assay demonstrated no significant cytotoxicity in J774 cells. However, essential oil indicated a more cytotoxic effect as compared with the methanolic extract of M. communis. The findings of the present study demonstrated that M. communis might be a natural source for production of a new leishmanicidal agent.
Animals
;
Antiprotozoal Agents/isolation & purification/*pharmacology/toxicity
;
Cell Line
;
Cell Survival/drug effects
;
Cyclohexanols/isolation & purification/pharmacology/toxicity
;
Inhibitory Concentration 50
;
Leishmania tropica/*drug effects/physiology
;
Macrophages/drug effects
;
Mice
;
Monoterpenes/isolation & purification/pharmacology/toxicity
;
Myrtus/*chemistry
;
Oils, Volatile/isolation & purification/*pharmacology/toxicity
;
Plant Extracts/isolation & purification/*pharmacology/toxicity
3.Antileishmanial and Cytotoxic Effects of Essential Oil and Methanolic Extract of Myrtus communis L..
Hossein MAHMOUDVAND ; Fatemeh EZZATKHAH ; Fariba SHARIFIFAR ; Iraj SHARIFI ; Ebrahim Saedi DEZAKI
The Korean Journal of Parasitology 2015;53(1):21-27
Plants used for traditional medicine contain a wide range of substances that can be used to treat various diseases such as infectious diseases. The present study was designed to evaluate the antileishmanial effects of the essential oil and methanolic extract of Myrtus communis against Leishmania tropica on an in vitro model. Antileishmanial effects of essential oil and methanolic extract of M. communis on promastigote forms and their cytotoxic activities against J774 cells were evaluated using MTT assay for 72 hr. In addition, their leishmanicidal activity against amastigote forms was determined in a macrophage model, for 72 hr. Findings showed that the main components of essential oil were alpha-pinene (24.7%), 1,8-cineole (19.6%), and linalool (12.6%). Findings demonstrated that M. communis, particularly its essential oil, significantly (P<0.05) inhibited the growth rate of promastigote and amastigote forms of L. tropica based on a dose-dependent response. The IC50 values for essential oil and methanolic extract was 8.4 and 28.9 mug/ml against promastigotes, respectively. These values were 11.6 and 40.8 mug/ml against amastigote forms, respectively. Glucantime as control drug also revealed IC50 values of 88.3 and 44.6 mug/ml for promastigotes and amastigotes of L. tropica, respectively. The in vitro assay demonstrated no significant cytotoxicity in J774 cells. However, essential oil indicated a more cytotoxic effect as compared with the methanolic extract of M. communis. The findings of the present study demonstrated that M. communis might be a natural source for production of a new leishmanicidal agent.
Animals
;
Antiprotozoal Agents/isolation & purification/*pharmacology/toxicity
;
Cell Line
;
Cell Survival/drug effects
;
Cyclohexanols/isolation & purification/pharmacology/toxicity
;
Inhibitory Concentration 50
;
Leishmania tropica/*drug effects/physiology
;
Macrophages/drug effects
;
Mice
;
Monoterpenes/isolation & purification/pharmacology/toxicity
;
Myrtus/*chemistry
;
Oils, Volatile/isolation & purification/*pharmacology/toxicity
;
Plant Extracts/isolation & purification/*pharmacology/toxicity
4.Visceral Leishmaniasis in Rural Areas of Alborz Province of Iran and Implication to Health Policy.
Aliehsan HEIDARI ; Mehdi MOHEBALI ; Kourosh KABIR ; Hojatallah BARATI ; Yousef SOULTANI ; Hossein KESHAVARZ ; Behnaz AKHOUNDI ; Homa HAJJARAN ; Hosein REISI
The Korean Journal of Parasitology 2015;53(4):379-383
Visceral leishmaniasis (VL) or kala-azar mainly affects children in endemic areas. This study was conducted to determine the seroprevalence of VL using direct agglutination test (DAT) in children living in rural districts of Alborz Province located 30 km from Tehran capital city of Iran. Multi-stage cluster random sampling was applied. Blood samples were randomly collected from 1,007 children under 10 years of age in the clusters. A total of 37 (3.7%) of the studied population showed anti-Leishmania infantum antibodies with titers of > or =1:800. There was a significant association between positive sera and various parts of the rural areas of Alborz Province (P<0.002). Two children with anti-Leishmania infantum antibodies titers of > or =1:3,200 indicated kala-azar clinical features and treated with anti-leishmaniasis drugs in pediatric hospital. The findings of this study indicated that Leishmania infection is prevalent in rural areas of Alborz Province. Therefore, it is necessary to increase the awareness and alertness among physicians and public health managers, particularly in high-risk rural areas of the province in Iran.
Antibodies, Protozoan/blood
;
Child
;
Child, Preschool
;
Female
;
Health Policy
;
Humans
;
Iran/epidemiology
;
Leishmania infantum/immunology/isolation & purification/physiology
;
Leishmaniasis, Visceral/blood/*epidemiology/parasitology
;
Male
;
*Rural Health
;
Seroepidemiologic Studies
5.An Autochthonous Case of Canine Visceral Leishmaniasis in Korea.
Dong Ha BHANG ; Ul Soo CHOI ; Hyun Jeong KIM ; Kyoung Oh CHO ; Sung Shik SHIN ; Hee Jeong YOUN ; Cheol Yong HWANG ; Hwa Young YOUN
The Korean Journal of Parasitology 2013;51(5):545-549
A 12-year-old spayed female mixed-bred dog presented with nasal bleeding of 2 days duration and a skin nodule in the left flank. No abnormalities were found in coagulation profiles and blood pressure. Cytological evaluation of the nodule revealed numerous characteristic round organisms having a nucleus and a bar within macrophages and in the background, consistent with leishmaniasis. In vitro culture was unsuccessful but PCR of the nodular aspirate identified the organisms as Leishmania infantum, and the final diagnosis was canine leishmaniasis. No history of travel to endemic countries was noted. Because the dog had received a blood transfusion 2 years before the illness, serological screening tests were performed in all donor dogs of the commercial blood bank using the commercial Leishmania ELISA test kit, and there were no positive results. Additional 113 dogs with hyperglobulinemia from Seoul were also screened with the same kits but no positive results were obtained. To the best of the author's knowledge this is the first autochthonous case of canine leishmaniasis in Korea.
Animals
;
Base Sequence
;
DNA, Protozoan/chemistry/genetics
;
DNA, Ribosomal/chemistry/genetics
;
Dog Diseases/*diagnosis/epidemiology
;
Dogs
;
Enzyme-Linked Immunosorbent Assay/veterinary
;
Female
;
Giant Cells/pathology
;
Leishmania infantum/genetics/immunology/*isolation & purification
;
Leishmaniasis, Visceral/diagnosis/*veterinary
;
Molecular Sequence Data
;
Polymerase Chain Reaction/veterinary
;
Protozoan Proteins/genetics
;
Republic of Korea
;
Sequence Analysis, DNA/veterinary
;
Serologic Tests/veterinary
6.Overexpression of Ubiquitin and Amino Acid Permease Genes in Association with Antimony Resistance in Leishmania tropica Field Isolates.
Elham KAZEMI-RAD ; Mehdi MOHEBALI ; Mohammad Bagher KHADEM-ERFAN ; Homa HAJJARAN ; Ramtin HADIGHI ; Ali KHAMESIPOUR ; Sassan REZAIE ; Mojtaba SAFFARI ; Reza RAOOFIAN ; Mansour HEIDARI
The Korean Journal of Parasitology 2013;51(4):413-419
The mainstay therapy against leishmaniasis is still pentavalent antimonial drugs; however, the rate of antimony resistance is increasing in endemic regions such as Iran. Understanding the molecular basis of resistance to antimonials could be helpful to improve treatment strategies. This study aimed to recognize genes involved in antimony resistance of Leishmania tropica field isolates. Sensitive and resistant L. tropica parasites were isolated from anthroponotic cutaneous leishmaniasis patients and drug susceptibility of parasites to meglumine antimoniate (Glucantime(R)) was confirmed using in vitro assay. Then, complementary DNA-amplified fragment length polymorphism (cDNA-AFLP) and real-time reverse transcriptase-PCR (RT-PCR) approaches were utilized on mRNAs from resistant and sensitive L. tropica isolates. We identified 2 known genes, ubiquitin implicated in protein degradation and amino acid permease (AAP3) involved in arginine uptake. Also, we identified 1 gene encoding hypothetical protein. Real-time RT-PCR revealed a significant upregulation of ubiquitin (2.54-fold), and AAP3 (2.86-fold) (P<0.05) in a resistant isolate compared to a sensitive one. Our results suggest that overexpression of ubiquitin and AAP3 could potentially implicated in natural antimony resistance.
Amino Acid Transport Systems/*genetics/metabolism
;
Antimony/*pharmacology
;
Antipruritics/*pharmacology
;
*Drug Resistance
;
Humans
;
Leishmania tropica/drug effects/enzymology/*genetics/isolation & purification
;
Leishmaniasis, Cutaneous/*parasitology
;
Protozoan Proteins/*genetics/metabolism
;
Ubiquitin/*genetics/metabolism
7.20-year search on molecular markers of Leishmania isolates from different Kala-azar foci in China to confirm whether genetic fingerprints of Kala-azar pathogens correlate with disease types.
Ying MA ; Lingyi BU ; Xiaosu HUA
Journal of Biomedical Engineering 2011;28(5):997-1000
Leishmaniasis (Kala-azar) from different endemic regions of China expresses different clinic and epidemiological features, and traditionally is classified as hilly, plain and desert types/foci. We concentrated our review on whether the pathogens from those foci were different at molecular level, if so, whether there are were molecular markers readily identifiable by molecular technologies. This was a review of a 20-year search for such markers by using kinetoplastic DNA (kDNA), nDNA hybridization, PCR-SSCP, RAPD and sequence analysis of SSU rDNA variable regions and LACK gene. The results showed that heterogeneities at molecular level exist in Leishmania isolated from different foci of China, which could be used as markers for different types of Leishmaniasis in China.
China
;
DNA Fingerprinting
;
DNA, Protozoan
;
analysis
;
genetics
;
Genotype
;
Humans
;
Leishmania donovani
;
classification
;
genetics
;
isolation & purification
;
Leishmaniasis, Visceral
;
classification
;
parasitology
;
Mutation
8.A Case of Post Kala-Azar Dermal Leishmaniasis in India.
Kalpalata TRIPATHY ; Aparijita MISRA ; Rabinarayn MALLIK ; Debiprasad MISRA ; Niranjan ROUT ; Jayshree RATH
The Korean Journal of Parasitology 2010;48(3):245-246
Post kala-azar dermal leishmaniasis (PKDL) is a rare disease. This is a solitary case report from Orissa, India. We describe a case of PKDL in a 55-year-old male who presented with multiple nodular lesions over face, trunk, and extremities. The patient had been to an endemic area of kala-azar and had a previous history of leishmaniasis. Fine needle aspiration cytology samples from skin nodules revealed Leishmania amastigotes.
Antimony Sodium Gluconate/therapeutic use
;
Antiprotozoal Agents/therapeutic use
;
Humans
;
India
;
Leishmania/isolation & purification
;
Leishmaniasis, Visceral/diagnosis/drug therapy/*parasitology/pathology
;
Male
;
Middle Aged
;
Skin/*parasitology/pathology
9.Clinical analysis on 28 patients with hemophagocytic lymphohistiocytosis syndrome.
Mi-Mi SHU ; Hua-Feng ZHU ; Tao ZHANG ; Guang-Xun GAO ; Xie-Qun CHEN
Journal of Experimental Hematology 2010;18(2):463-465
In order to profoundly understand the clinical and laboratorial characteristics and inducing factors of hemophagocytic lymphohistiocytosis syndrome (HLH), 28 HLH patients received from 2004 to 2009 years in our hospital were analyzed retrospectively. The results indicated that all of the patients had a history with prolonged fever (more than 1 week), pancytopenia, hepatosplenomegaly, elevated ferritin level, hypofibrinogen, and hemophagocytosis in bone marrow. HLH was the first characteristic sign of malignant lymphoma in 9 patients; 1 patient had a clinical manifestation similar to fulminant hepatic failure; severe psycho-abnormality occurred in 1 HLH patient and pronounced hemophagocytosis were detected in his cerebrospinal fluid; 1 patient was eventually diagnosed as having HLH by the findings in a lymph node biopsy showing obvious hemophagocytosis. Additionally, the analysis of underlying factors in 28 patients with HLH indicated 11 patients with EB virus-associated HLH, 11 with lymphoma-associated HLH, 2 with Leishmania-associated HLH, and 3 with autoimmune disease-associated HLH. It is concluded that HLH disease is characterised with high heterogenicity in both clinical features and inducing factors; in addition, the patients from a pasturing area should be paid attention to parasite infection such as leishmania.
Adolescent
;
Adult
;
Aged
;
Autoimmune Diseases
;
complications
;
Child
;
Child, Preschool
;
Female
;
Herpesvirus 4, Human
;
isolation & purification
;
Humans
;
Leishmania
;
isolation & purification
;
Lymphohistiocytosis, Hemophagocytic
;
complications
;
diagnosis
;
parasitology
;
virology
;
Male
;
Middle Aged
;
Retrospective Studies
;
Young Adult
10.Aureobasidium-Derived Soluble Branched (1,3-1,6) beta-Glucan (Sophy beta-glucan) Enhances Natural Killer Activity in Leishmania amazonensis-Infected Mice.
Lalani YATAWARA ; Susiji WICKRAMASINGHE ; Mitsuru NAGATAKI ; Misa TAKAMOTO ; Haruka NOMURA ; Yasunori IKEUE ; Yoshiya WATANABE ; Takeshi AGATSUMA
The Korean Journal of Parasitology 2009;47(4):345-351
The beta-glucans derived from yeast cell walls have been reported for having many immunomodulatory activities in vivo and in vitro. In this study, Aureobasidium-derived soluble branched (1,3-1,6) beta-glucan (Sophy beta-glucan) was checked for natural killer (NK) activity and for the production of IFN-gamma and IL-4 in Leishmania amazonensis infection. The main experiment was performed with a group of female C57BL/6 and BALB/c mice, orally supplemented with 5% of Sophy beta-glucan and infected with promastogotes of L. amazonensis (1 x 10(7)) into the footpad. Increase in the footpad thickness with time was observed in BALB/c mice in spite of the oral Sophy beta-glucan supplement, but it was less in C57BL/6 mice. The difference in overall mean footpad thickness between 'infection only' versus 'infection + glucan' groups was statistically significant (P < 0.001). High NK activity in C57BL/6 than BALB/c mice was observed in 'glucan only' group compared to the control group and also in 'infection + glucan' group compared to 'infection only' group. The difference in the NK activity among these groups was significant (P < 0.05). The IFN-gamma level increased at weeks 7 and 8 post-infection in C57BL/6 mice and was significantly high in 'infection + glucan' group compared to the 'infection only' group (P < 0.05). IL-4 levels did not increase up to detectable levels throughout the study. The results led a conclusion that Sophy beta-glucan enhances NK activity and cellular immunity in L. amazonensis-infected mice.
Administration, Oral
;
Animals
;
Ascomycota/*chemistry
;
Cytotoxicity Tests, Immunologic
;
Female
;
Foot/pathology
;
Glucans/administration & dosage/*isolation & purification/pharmacology/*therapeutic use
;
Immunologic Factors/administration & dosage/*isolation & purification/pharmacology/*therapeutic use
;
Interferon-gamma/biosynthesis
;
Interleukin-4/biosynthesis
;
Killer Cells, Natural/drug effects/*immunology
;
Leishmania mexicana/*immunology
;
Leishmaniasis, Cutaneous/*drug therapy/immunology/pathology
;
Mice
;
Mice, Inbred BALB C
;
Mice, Inbred C57BL
;
Severity of Illness Index
;
Time Factors

Result Analysis
Print
Save
E-mail